The Anterior Gradient-2 Pathway as a Model for Developing Peptide-Aptamer Anti-Cancer Drug Leads that Stimulate p53 Function

Publisher： Bentham Science Publishers

E-ISSN： 1872-3136 |3|2|124-137

ISSN： 2212-7968

Source： Current Chemical Biology, Vol.3, Iss.2, 2009-05, pp. : 124-137

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Cancer Drug Design Using Natural and Synthetic Pharmacophores

By  

Current Organic Chemistry, Vol. 19, Iss. 15, 2015-01 ,pp. : 1460-1490

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Recent Developments in the Chemistry of Anti-Cancer Drug Research)

By  

Current Organic Chemistry, Vol. 19, Iss. 10, 2015-05 ,pp. : 870-870

Bentham Science Publishers

Access to resources Recommend Favorite

Polyphyllin D - A Potential Anti-Cancer Agent to Kill Hepatocarcinoma Cells with Multi-Drug Resistance

By  

Current Chemical Biology, Vol. 3, Iss. 1, 2009-01 ,pp. : 89-99

Bentham Science Publishers

Access to resources Recommend Favorite

Reactive Oxygen Species, Cancer and Anti-Cancer Therapies

By  

Current Chemical Biology, Vol. 3, Iss. 1, 2009-01 ,pp. : 22-46

Bentham Science Publishers

Access to resources Recommend Favorite

Regulation of p53 Activity

By  

Current Chemical Biology, Vol. 4, Iss. 1, 2010-01 ,pp. : 1-12

Bentham Science Publishers

Access to resources Recommend Favorite